TY - JOUR
T1 - Synaptopathies
T2 - synaptic dysfunction in neurological disorders - A review from students to students
AU - Lepeta, Katarzyna
AU - Lourenco, Mychael V
AU - Schweitzer, Barbara C
AU - Martino Adami, Pamela V
AU - Banerjee, Priyanjalee
AU - Catuara-Solarz, Silvina
AU - de La Fuente Revenga, Mario
AU - Guillem, Alain Marc
AU - Haidar, Mouna
AU - Ijomone, Omamuyovwi M
AU - Nadorp, Bettina
AU - Qi, Lin
AU - Perera, Nirma D
AU - Refsgaard, Louise K
AU - Reid, Kimberley M
AU - Sabbar, Mariam
AU - Sahoo, Arghyadip
AU - Schaefer, Natascha
AU - Sheean, Rebecca K
AU - Suska, Anna
AU - Verma, Rajkumar
AU - Vicidomini, Cinzia
AU - Wright, Dean
AU - Zhang, Xing-Ding
AU - Seidenbecher, Constanze
N1 - © 2016 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Abstract: Synapses are essential components of neurons and allow information to travel coordinately throughout the nervous system to adjust behavior to environmental stimuli and to control body functions, memories, and emotions. Thus, optimal synaptic communication is required for proper brain physiology, and slight perturbations of synapse function can lead to brain disorders. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant of many neurological diseases. This notion has led to the concept of synaptopathies as brain diseases with synapse defects as shared pathogenic features. In this review, which was initiated at the 13th International Society for Neurochemistry Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental disorders (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer and Parkinson disease). We finally discuss the appropriateness and potential implications of gathering synapse diseases under a single term. Understanding common causes and intrinsic differences in disease-associated synaptic dysfunction could offer novel clues toward synapse-based therapeutic intervention for neurological and neuropsychiatric disorders. (Figure presented.) In this Review, which was initiated at the 13th International Society for Neurochemistry (ISN) Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer's and Parkinson's diseases), gathered together under the term of synaptopathies. Read the Editorial Highlight for this article on page 783.
AB - Abstract: Synapses are essential components of neurons and allow information to travel coordinately throughout the nervous system to adjust behavior to environmental stimuli and to control body functions, memories, and emotions. Thus, optimal synaptic communication is required for proper brain physiology, and slight perturbations of synapse function can lead to brain disorders. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant of many neurological diseases. This notion has led to the concept of synaptopathies as brain diseases with synapse defects as shared pathogenic features. In this review, which was initiated at the 13th International Society for Neurochemistry Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental disorders (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer and Parkinson disease). We finally discuss the appropriateness and potential implications of gathering synapse diseases under a single term. Understanding common causes and intrinsic differences in disease-associated synaptic dysfunction could offer novel clues toward synapse-based therapeutic intervention for neurological and neuropsychiatric disorders. (Figure presented.) In this Review, which was initiated at the 13th International Society for Neurochemistry (ISN) Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer's and Parkinson's diseases), gathered together under the term of synaptopathies. Read the Editorial Highlight for this article on page 783.
KW - Journal Article
KW - Review
U2 - 10.1111/jnc.13713
DO - 10.1111/jnc.13713
M3 - Journal article
C2 - 27333343
SN - 0022-3042
VL - 138
SP - 785
EP - 805
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 6
ER -